BACKGROUND AND AIM OF THE STUDY: The association between aortic valve allograft dysfunction in @entity1 with long-term follow up and @entity1 leukocyte class 2 antigen donor/recipient mismatch suggests that elements of the anti-donor immune response penetrate and damage the aortic valve allograft. An aortic valve allograft recipient cohort was studied to determine whether presence of recipient antibodies to donor @entity1 leukocyte class 1 or 2 antigen was associated with shorter time to aortic valve allograft dysfunction. METHODS: Both donor and recipient human leukocyte antigen (HLA) type, HLA antibody information and echocardiography data were available for 148 recipients of cryopreserved aortic valve allografts between 1986 and 1998. Structural deterioration of the aortic valve allograft was defined as at least moderate @entity472 or regurgitation by echocardiography. Recipient sera were assayed for anti-HLA (class 1 and 2) antibodies using three assays: complement-dependent @entity137 (CDC) on T- and B-lymphocyte panels (CDC PRA); flow cytometry using HLA-coated beads (Flow PRA); and an ELISA using HLA-coated microwells. The donor specificity of anti-class 1 and 2 HLA antibodies was determined on T- and B-cell panels using CDC. Associations between the results of the three assays and donor-specific class 1 and 2 antibodies and @entity2383 were analyzed using Kaplan-Meier curves of freedom from structural deterioration. Cox proportional-hazards were used to determine independent predictors of @entity2383 . RESULTS: @entity1 highly positive for HLA class 2 antibodies using an ELISA had a significant association (p = 0.007) with shorter time to aortic @entity2383 using both a log rank test and Cox proportional-hazards analysis. @entity1 (n = 15) with donor-specific antibodies to class 2 antigen (DR antigens) had significantly more structural deterioration (p = 0.035) than those without specific antibodies. CONCLUSION: The association between aortic @entity2383 and high titer @entity1 leukocyte class 2 antigen antibodies, a subset detected by ELISA adds further information about the link between HLA class 2 mismatch and structural deterioration. Further studies are needed to confirm the importance of class 2 antibodies on outcome, and to determine by which method these antibodies should be detected. Potential recipients with pre-existing antibodies of these specific types might be expected to sustain accelerated allograft damage.

Aortic XXXX is associated with a subset of antibodies to human leukocyte antigens.

@entity1 :: ('9606', 'Species') :: ['Patients', 'human', 'patients'] @entity472 :: ('MESH:D001024', 'Disease') :: ['aortic stenosis'] @entity137 :: ('MESH:D064420', 'Disease') :: ['cytotoxicity'] @entity2383 :: ('MESH:D028361', 'Disease') :: ['valve allograft structural deterioration', 'time to structural deterioration']
@entity2383 :: (MESH:D028361,Disease) :: ['valve allograft structural deterioration']
